- Report
- November 2024
- 50 Pages
Global
From €2633EUR$2,650USD£2,189GBP
- Report
- November 2024
- 50 Pages
Global
From €2633EUR$2,650USD£2,189GBP
- Report
- November 2024
- 50 Pages
Global
From €2633EUR$2,650USD£2,189GBP
- Report
- November 2024
- 50 Pages
Global
From €2633EUR$2,650USD£2,189GBP
- Report
- November 2024
- 50 Pages
Global
From €2633EUR$2,650USD£2,189GBP
- Report
- November 2024
- 50 Pages
Global
From €2633EUR$2,650USD£2,189GBP
- Report
- March 2024
- 132 Pages
Global
From €944EUR$950USD£785GBP
- Report
- March 2024
- 132 Pages
Global
From €944EUR$950USD£785GBP
- Report
- May 2024
- 70 Pages
United States
From €4918EUR$4,950USD£4,089GBP
- Report
- January 2024
- 94 Pages
North America
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- December 2023
- 96 Pages
Africa, Middle East
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- December 2023
- 113 Pages
Europe
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- December 2023
- 106 Pages
Asia Pacific
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3442EUR$3,465USD£2,862GBP
€4918EUR$4,950USD£4,089GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3442EUR$3,465USD£2,862GBP
€4918EUR$4,950USD£4,089GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3442EUR$3,465USD£2,862GBP
€4918EUR$4,950USD£4,089GBP
- Report
- April 2024
- 147 Pages
United States
From €2979EUR$2,999USD£2,477GBP
- Report
- December 2023
- 160 Pages
Asia Pacific
From €2979EUR$2,999USD£2,477GBP
- Report
- December 2023
- 158 Pages
Middle East, Africa, Europe Middle East, Africa, Europe
From €2979EUR$2,999USD£2,477GBP
- Report
- December 2023
- 152 Pages
Latin America
From €2979EUR$2,999USD£2,477GBP
The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more